Skip to main content
Trending storyContinuously updated

Treat raises €3M pre-seed led by byFounders and Illusian

2 reports1 report sources21 hours agoUpdate

Get up to speed on this story

AI Summary

Finnish healthtech startup Treat raised a €3M pre-seed round led by byFounders and Illusian, the fund of Supercell founder Ilkka Paananen. Treat uses AI intake to brief doctors on a patient's history before a digital consultation, aiming to resolve most cases in one visit rather than through repeat appointments. The company is co-founded by former Swappie CEO Sami Marttinen. Treat is sold to employers as a benefit for their employees, complementing existing private health insurance and occupational healthcare.

AI-generated from reports · 21 hours agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 16
  1. Tech.eu
    European Tech Weekly Recap: €2.3B in Deals and October's Funding Highlights

    European tech startups raised €6B across 288 deals in October, down about 62% in value from September.

  2. Tech.euTop Deals
    Finnish healthtech Treat raises €3M pre-seed led by byFounders and Illusian

    Treat, a Finnish healthtech startup, raised a €3M pre-seed round led by byFounders and Supercell founder Ilkka Paananen's Illusian. The company uses AI intake to brief doctors on patient history before a digital consultation, aiming to resolve most cases in one visit instead of repeat appointments. It is co-founded by former Swappie CEO Sami Marttinen and is sold to employers alongside private insurance.

Trend for this story

Comparable range current
6
Comparable range peak
10Nov 16 15:00
Change in the last 24 hours
–

Trends only compare the same entities observed consistently and completely, so the scope may be smaller than the current trending statistics. Move the pointer or click the chart to view hourly trending; use the left and right arrow keys on a keyboard to switch.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing